{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:21:00Z","timestamp":1777479660366,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2014A020212597"],"award-info":[{"award-number":["2014A020212597"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bcp.2021.114579","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T02:43:54Z","timestamp":1619145834000},"page":"114579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Spleen tyrosine kinase (SYK) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction"],"prefix":"10.1016","volume":"188","author":[{"given":"Gang","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dantao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jican","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haotian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114579_b0005","doi-asserted-by":"crossref","DOI":"10.7326\/AITC201708010","article-title":"Osteoporosis","volume":"167","author":"Ensrud","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.bcp.2021.114579_b0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"S3","key":"10.1016\/j.bcp.2021.114579_b0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","article-title":"Incidence and mortality and epidemiology of breast cancer in the world","volume":"17","author":"Ghoncheh","year":"2016","journal-title":"Asian Pac. J. Cancer Prevent."},{"issue":"1","key":"10.1016\/j.bcp.2021.114579_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2014.01.002","article-title":"RANKL, RANK from bone physiology to breast cancer","volume":"25","author":"Sigl","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.bcp.2021.114579_b0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diab. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114579_b0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jama.2020.2923","article-title":"Bisphosphonates for postmenopausal osteoporosis","volume":"325","author":"Ensrud","year":"2021","journal-title":"JAMA"},{"issue":"10109","key":"10.1016\/j.bcp.2021.114579_b0040","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(17)32850-7","article-title":"Bisphosphonates in osteoporosis: NICE and easy?","volume":"390","author":"Harvey","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.bcp.2021.114579_b0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jjco\/hys088","article-title":"Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancer","volume":"42","author":"Kurata","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114579_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"6554","key":"10.1016\/j.bcp.2021.114579_b0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"issue":"6554","key":"10.1016\/j.bcp.2021.114579_b0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bcp.2021.114579_b0065","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0401602101","article-title":"The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase","volume":"101","author":"M\u00f3csai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.bcp.2021.114579_b0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.200611083","article-title":"Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption","volume":"176","author":"Zou","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114579_b0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2019.00937","article-title":"Hematopoietic or osteoclast-specific deletion of Syk leads to increased bone mass in experimental mice","volume":"10","author":"Csete","year":"2019","journal-title":"Front. Immunol."},{"issue":"6797","key":"10.1016\/j.bcp.2021.114579_b0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/35021086","article-title":"The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells","volume":"406","author":"Coopman","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2021.114579_b0085","doi-asserted-by":"crossref","first-page":"e7445","DOI":"10.1371\/journal.pone.0007445","article-title":"Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo","volume":"4","author":"Sung","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2021.114579_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121974","article-title":"The Syk kinase promotes mammary epithelial integrity and inhibits breast cancer invasion by stabilizing the E-cadherin\/catenin complex","volume":"11","author":"Kassouf","year":"2019","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.bcp.2021.114579_b0095","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.18632\/oncotarget.27545","article-title":"Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells","volume":"11","author":"Lamb","year":"2020","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bcp.2021.114579_b0100","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/0008-5472.CAN-18-2636","article-title":"Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer","volume":"79","author":"Shinde","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114579_b0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI28775","article-title":"PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2","volume":"116","author":"Mao","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2021.114579_b0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2362.2011.02556.x","article-title":"Phospholipase C\u03b32 is required for basal but not oestrogen deficiency-induced bone resorption","volume":"42","author":"Kert\u00e9sz","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2021.114579_b0115","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1021\/acs.jnatprod.5b00233","article-title":"Harpagoside inhibits RANKL-induced osteoclastogenesis via Syk-Btk-PLC\u03b32-Ca(2+) signaling pathway and prevents inflammation-mediated bone loss","volume":"78","author":"Kim","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bcp.2021.114579_b0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4068\/cmj.2016.52.1.12","article-title":"Signaling pathways in osteoclast differentiation","volume":"52","author":"Kim","year":"2016","journal-title":"Chonnam Med. J."},{"issue":"5","key":"10.1016\/j.bcp.2021.114579_b0125","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/jcp.26161","article-title":"Mammalian target of rapamycin as a therapeutic target in osteoporosis","volume":"233","author":"Shen","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114579_b0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/annonc\/mdz133","article-title":"Targeting the PI3-kinase pathway in triple-negative breast cancer","volume":"30","author":"Pascual","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2021.114579_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semcancer.2019.08.005","article-title":"Recent nanotechnological interventions targeting PI3K\/Akt\/mTOR pathway: a focus on breast cancer","volume":"59","author":"Sharma","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.111.188441","article-title":"Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis","volume":"340","author":"Coffey","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jcph.794","article-title":"PRT062607 achieves complete inhibition of the spleen tyrosine kinase at tolerated exposures following oral dosing in healthy volunteers","volume":"57","author":"Coffey","year":"2017","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114579_b0150","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.16","article-title":"Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis","volume":"1","author":"Coffey","year":"2013","journal-title":"Pharmacol. Res. Perspect."},{"issue":"23","key":"10.1016\/j.bcp.2021.114579_b0160","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41388-019-0734-5","article-title":"Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis","volume":"38","author":"Torres-Hernandez","year":"2019","journal-title":"Oncogene"},{"issue":"88","key":"10.1016\/j.bcp.2021.114579_b0165","doi-asserted-by":"crossref","DOI":"10.3791\/51046-v","article-title":"In vitro cell migration and invasion assays","author":"Justus","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.bcp.2021.114579_b0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10585-005-0365-9","article-title":"An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis","volume":"22","author":"Luu","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bcp.2021.114579_b0175","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.biopha.2018.08.018","article-title":"Postmenopausal osteoporosis and breast cancer: the biochemical links and beneficial effects of functional foods","volume":"107","author":"Muhammad","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bcp.2021.114579_b0180","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jbmr.3449","article-title":"Second-generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the cherubism mouse model","volume":"33","author":"Yoshimoto","year":"2018","journal-title":"J. Bone Mineral Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00223-009-9331-x","article-title":"Effects of altered bone remodeling and retention of cement lines on bone quality in osteopetrotic aged c-Src-deficient mice","volume":"86","author":"Nakayama","year":"2010","journal-title":"Calcified Tissue Int."},{"issue":"4","key":"10.1016\/j.bcp.2021.114579_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042097","article-title":"Pax5 negatively regulates osteoclastogenesis through downregulation of Blimp 1","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2021.114579_b0195","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/jbmr.131","article-title":"Dysosteosclerosis presents as an \u201costeoclast-poor\u201d form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review","volume":"25","author":"Whyte","year":"2010","journal-title":"J. Bone Mineral Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114579_b0200","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2021.114579_b0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bone.2013.12.013","article-title":"Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC\u03b32-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice","volume":"60","author":"Kim","year":"2014","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bcp.2021.114579_b0210","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2021.114579_b0215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2021.114579_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","article-title":"PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux","volume":"48","author":"O'Donnell","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114579_b0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:06:36Z","timestamp":1777385196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":45,"alternative-id":["S0006295221001854"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114579","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spleen tyrosine kinase (SYK) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114579"}}